IGT-303
/ INGENIA Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
November 18, 2025
A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
(clinicaltrials.gov)
- P1/2 | N=94 | Not yet recruiting | Sponsor: Ingenia Therapeutics INC
New P1/2 trial • Chronic Kidney Disease • Nephrology • Renal Disease
October 08, 2026
A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
(clinicaltrials.gov)
- P1/2 | N=94 | Recruiting | Sponsor: Ingenia Therapeutics INC | Trial completion date: Jan 2027 ➔ Apr 2027
Trial completion date • Chronic Kidney Disease • Nephrology • Renal Disease
December 06, 2025
A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
(clinicaltrials.gov)
- P1/2 | N=94 | Recruiting | Sponsor: Ingenia Therapeutics INC | Not yet recruiting ➔ Recruiting
Enrollment open • Chronic Kidney Disease • Nephrology • Renal Disease
1 to 3
Of
3
Go to page
1